Dynocardia, Inc.

medical devices

About

Dynocardia, Inc. is a Boston-based medical device company founded in September 2018. The company focuses on developing innovative biomedical technologies to enhance healthcare globally. Dynocardia emerged from research at MIT and Tufts Medical, with support from NIH grants. Its flagship product, ViTrack™, is a first-of-its-kind, cuff-less wearable device designed for continuous, non-invasive blood pressure monitoring. ViTrack™ utilizes a proprietary optical force sensor and advanced motion-correction algorithms to provide accurate beat-to-beat blood pressure readings. In addition to blood pressure, the device also measures heart rate, heart rhythm, and respiratory metrics, making it suitable for various applications, including outpatient diagnosis, in-hospital monitoring, and remote patient care. Dynocardia is actively engaged in clinical validation and regulatory processes to bring its technology to market, targeting healthcare providers, hospitals, and consumers interested in wellness and disease prevention.

Technologies

NSOne Gmail Google Apps Typekit YouTube Mobile Friendly Squarespace ECommerce Remote Circle AI

Keywords

biomedical cardiovascular cnibp blood pressure measurement kymograph medical device hypertension vital signs monitoring medical equipment manufacturing biotechnology healthcare innovation medical devices motion correction technology clinical trials healthcare equipment & supplies blood pressure monitoring patient monitoring wearable health device artificial touch sensing cuff-less bp device motion-artifact mitigation in silico clinical trials hemodynamic parameters non-invasive bp measurement predictive analytics healthtech remote patient monitoring government maternal health monitoring

Location

1 Broadway, Cambridge, Massachusetts, United States, 02142

Related Companies

Companies in the same industry